Correlation Between SeqLL Warrant and Dermata Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SeqLL Warrant and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SeqLL Warrant and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SeqLL Warrant and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on SeqLL Warrant and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SeqLL Warrant with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SeqLL Warrant and Dermata Therapeutics.

Diversification Opportunities for SeqLL Warrant and Dermata Therapeutics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between SeqLL and Dermata is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding SeqLL Warrant and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and SeqLL Warrant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SeqLL Warrant are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of SeqLL Warrant i.e., SeqLL Warrant and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between SeqLL Warrant and Dermata Therapeutics

If you would invest  1.78  in Dermata Therapeutics Warrant on September 12, 2024 and sell it today you would lose (0.86) from holding Dermata Therapeutics Warrant or give up 48.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.64%
ValuesDaily Returns

SeqLL Warrant  vs.  Dermata Therapeutics Warrant

 Performance 
       Timeline  
SeqLL Warrant 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SeqLL Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, SeqLL Warrant is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Dermata Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dermata Therapeutics Warrant are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Dermata Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

SeqLL Warrant and Dermata Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SeqLL Warrant and Dermata Therapeutics

The main advantage of trading using opposite SeqLL Warrant and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SeqLL Warrant position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.
The idea behind SeqLL Warrant and Dermata Therapeutics Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine